Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Clinical trial NCT06731868 · RECRUITING

Trial details

NCT number: NCT06731868
Sponsor: Luye Pharma Group Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tardive Dyskinesia (TD)

Start date: 2025-01-14
Primary completion: 2025-10-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.